Zealand Pharma A/S | ZEAL - Stammkapital

Aktienkurs
265.10
Täglich Wechseln
2.30 0.88%
Monatlich
-32.04%
Jährlich
-54.72%
Q1 Prognose
222.73




Stammkapital Veränderung Datum
Akebia Therapeutics USD 2K 0 2025-03
Alaunos Therapeutics USD 2.21M 2.2M 2025-09
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 259.98M 18K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 14.86M 111.83K 2024-12
Tilray USD 1.06B 86.93M 2025-03
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 165.53M 165.51M 2025-09